http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105749356-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 |
filingDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105749356-B |
titleOfInvention | Active polysaccharide composite bone repairing material |
abstract | The invention discloses a kind of good biocompatibility, plasticity is strong, has certain mechanical strength, internal degradation speed moderate, it is able to satisfy the active polysaccharide composite bone repairing material of clinical demand, the composite material includes A bottles and B bottles, the A bottle includes the powder of tetracalcium phosphate, calcium monohydrogen phosphate, chitosan, sodium dihydrogen phosphate, hydroxypropyl methylcellulose, and the B bottle includes the bioactie agent dried frozen aquatic products of mannitol, MES aqueous solution and rhBMP-2.Bioactie agent can induce the formation of new bone to the material in vivo, form active mass, and have many advantages, such as that compatibility is good, and easy moulding, non-toxic reaction is closely connect after solidification with sclerotin. |
priorityDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.